Bone Marrow Transplant
A bone marrow transplant is a procedure that infuses healthy blood-forming stem cells into your body to replace bone marrow that’s not producing enough healthy blood cells. A bone marrow transplant is also called a stem cell transplant.
You might need a bone marrow transplant if your bone marrow stops working and does not produce enough healthy blood cells.
Bone marrow transplants may use cells from your own body (autologous transplant) or from a donor (allogeneic transplant).
- Allogeneic stem cell transplant
- Autologous stem cell transplant
A bone marrow transplant may be used to:
- Safely allow treatment with high doses of chemotherapy or radiation by replacing or rescuing the bone marrow damaged by the treatment.
- Replace bone marrow that’s not working properly with new stem cells.
- Provide new stem cells, which can help kill cancer cells directly.
Bone marrow transplants can benefit people with a variety of both cancerous and noncancerous diseases, including:
- Acute leukemia.
- Adrenoleukodystrophy.
- Aplastic anemia.
- Bone marrow failure syndromes.
- Chronic leukemia.
- Hemoglobinopathies.
- Hodgkin’s lymphoma.
- Immune deficiencies.
- Inborn errors of metabolism.
- Multiple myeloma.
- Myelodysplastic syndromes.
- Neuroblastoma.
- Non-Hodgkin’s lymphoma.
- Plasma cell disorders.
- POEMS syndrome.
- Primary amyloidosis.
A bone marrow transplant can pose numerous risks. Some people experience minimal problems with a bone marrow transplant, while others can have serious complications that require treatment or hospitalization. Sometimes complications are life-threatening.
Your risks depend on many factors, including the disease or condition that caused you to need a transplant, the type of transplant, your age and your overall health.
Possible complications from a bone marrow transplant include:
- Graft-versus-host disease (a complication of allogeneic transplant only).
- Stem cell (graft) failure.
- Organ damage.
- Infections.
- Cataracts.
- Infertility.
- New cancers.
- Death.
Your health care provider can explain your risk of complications from a bone marrow transplant. Together you can weigh the risks and benefits to decide whether a bone marrow transplant is right for you.
Graft-versus-host disease: A potential risk when stem cells come from donors
If you receive a transplant that uses stem cells from a donor (allogeneic transplant), you may be at risk of developing graft-versus-host disease (GVHD). This condition occurs when the donor stem cells that make up your new immune system see your body’s tissues and organs as something foreign and attack them.
GVHD may happen at any time after your transplant. Many people who have an allogeneic transplant get GVHD at some point. The risk of GVHD is greater if the stem cells come from an unrelated donor. But GVHD can happen to anyone who gets a bone marrow transplant from a donor.
There are two kinds of GVHD: acute and chronic. Acute GVHD usually happens during the first months after your transplant. It typically affects your skin, digestive tract or liver. Chronic GVHD typically develops later and can affect many organs.
Chronic GVHD signs and symptoms include:
- Joint or muscle pain.
- Shortness of breath.
- Persistent cough.
- Vision changes, such as dry eyes.
- Skin changes, including scarring under the skin or skin stiffness.
- Rash.
- Yellowing of the skin and the whites of your eyes.
- Dry mouth.
- Mouth sores.
- Diarrhea.
- Nausea.
- Vomiting.
A series of tests and procedures can assess your general health and the status of your condition. The tests and procedures also ensure that you’re physically prepared for the transplant. The evaluation may take several days or more.
In addition, a long, thin tube (intravenous catheter) will be implanted into a large vein in your chest or neck. The catheter, often called a central line, usually remains in place for the duration of your treatment. Your transplant team will use the central line to infuse the transplanted stem cells, medications and blood products into your body.
If a transplant using your own stem cells (autologous transplant) is planned, you’ll undergo a procedure called apheresis (af-uh-REE-sis) to collect blood stem cells.
Before apheresis, you’ll receive daily injections of growth factor to increase stem cell production and move stem cells into your circulating blood so that they can be collected.
During apheresis, blood is drawn from a vein and circulated through a machine. The machine separates your blood into different parts, including stem cells. These stem cells are collected and frozen for future use in the transplant. The remaining blood is returned to your body.
If you’re having a transplant using stem cells from a donor (allogeneic transplant), you’ll need a donor. Once a donor is found, stem cells are gathered from that person for the transplant.
Stem cells can come from your donor’s blood or bone marrow. Your transplant team decides which is better for you based on your situation.
Another type of allogeneic transplant uses stem cells from the blood of umbilical cords (cord blood transplant). Mothers can choose to donate umbilical cords after their babies’ births. The blood from these cords is frozen and stored in a cord blood bank until needed for a bone marrow transplant.
After completing the pretransplant tests and procedures, you’ll begin a process known as conditioning. During conditioning, you’ll undergo chemotherapy and possibly radiation to:
- Destroy cancer cells if you’re being treated for cancer that may spread to other parts of the body.
- Suppress your immune system.
- Prepare your bone marrow for the new stem cells.
The type of conditioning process you receive depends on several factors, including the disease being treated, your overall health and the type of transplant planned. You may have both chemotherapy and radiation or just one of these treatments as part of your conditioning treatment.
Side effects of the conditioning process can include:
- Nausea and vomiting.
- Diarrhea.
- Hair loss.
- Mouth sores or ulcers.
- Infection.
- Bleeding.
- Infertility or sterility.
- Anemia.
- Fatigue.
- Cataracts.
- Organ complications, such as heart, liver or lung failure.
You may be able to take medications or other measures to reduce such side effects.
Based on your age and health history, you may receive lower doses or different types of chemotherapy or radiation for your conditioning treatment. This is called reduced-intensity conditioning.
Reduced-intensity conditioning kills some cancer cells and suppresses your immune system. Then, the donor’s cells are infused into your body. Donor cells replace cells in your bone marrow over time. Immune factors in the donor cells may then fight your cancer cells.
Your bone marrow transplant occurs after you complete the conditioning process. On the day of your transplant, stem cells are infused into your body through your central line.
The transplant infusion is painless. You’ll be awake during the procedure.
When the new stem cells enter your body, they travel through your blood to your bone marrow. In time, they multiply and begin to make new, healthy blood cells. This is called engraftment. It usually takes several weeks before the number of blood cells in your body starts to return to the standard range. In some people, it may take longer.
In the days and weeks after your bone marrow transplant, you’ll have blood tests and other tests to monitor your condition. You may need medicine to manage complications, such as nausea and diarrhea.
After your bone marrow transplant, you’ll remain under close medical care. If you’re experiencing infections or other complications, you may need to stay in the hospital for several days or longer. Depending on the type of transplant and the risk of complications, you’ll need to remain near the hospital for several weeks to months to allow close monitoring.
You may also need periodic transfusions of red blood cells and platelets until your bone marrow begins producing enough of those cells on its own.
You may be at greater risk of infections or other complications for months to years after your transplant. For the rest of your life, you’ll meet regularly with your health care provider to check for late complications.
If your bone marrow transplant is using stem cells from a donor (allogeneic transplant), you may take medications to help prevent graft-versus-host disease (GVHD) and reduce your immune system’s reaction. These drugs are called immunosuppressive medications.
After your transplant, it takes time for your immune system to recover. During this time, you may be given medications to prevent infections.
After your bone marrow transplant, you may need to adjust your diet to stay healthy and to prevent excessive weight gain. Your nutrition specialist (dietitian) and other members of your transplant team will work with you to create a healthy-eating plan that meets your needs and complements your lifestyle. Your dietitian can also give you food suggestions to control side effects of chemotherapy and radiation, such as nausea.
Your dietitian can also give you food suggestions to control side effects of chemotherapy and radiation, such as nausea.
Some of your dietitian’s recommendations may include:
- Following food safety guidelines to prevent foodborne infections.
- Eating a wide variety of healthy foods, including vegetables; fruits; whole grains; lean meats, poultry and fish; legumes; and healthy fats, such as olive oil.
- Limiting salt intake.
- Restricting alcohol.
- Avoiding grapefruit and grapefruit juice due to their effect on a group of immunosuppressive medications.
After your bone marrow transplant, regular physical activity helps you control your weight, strengthen your bones, increase your endurance, strengthen your muscles and keep your heart healthy. As you recover, you can slowly increase your physical activity.
Taking steps to prevent cancer is even more important after your transplant. Don’t smoke. Wear sunscreen when you’re outside, and be sure to get recommended cancer screenings.
Results
A bone marrow transplant can cure some diseases and put others into remission. Goals of a bone marrow transplant depend on your condition but usually include controlling or curing your disease, extending your life, and improving your quality of life.
Some people have few side effects and complications from a bone marrow transplant. Others may experience short- and long-term side effects and complications. It can be difficult to predict the severity of side effects and the success of the transplant.
It can be helpful to remember that there are many people who have transplants who also experienced some very difficult days during the transplant process. But, ultimately, they had successful transplants and have returned to typical activities with good quality of life.
References
- AskMayoExpert. Hematopoietic stem cell transplant. Mayo Clinic; 2020.
- Hoffman R, et al. Overview and choice of donor of hematopoietic stem cell transplantation. In: Hematology: Basic Principles and Practice. 7th ed. Elsevier; 2018. https://www.clinicalkey.com. Accessed Jan. 28, 2022.
- Blood-forming stem cell transplants. National Cancer Institute. http://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/stem-cell-fact-sheet. Accessed Jan. 28, 2022.
- Majhail NS. How to perform hematopoietic stem cell transplantation. JACC CardioOncology. 2021; doi:10.1016/j.jaccao.2021.09.012.
- Diseases treatable by transplants. National Marrow Donor Program. https://bethematch.org/transplant-basics/how-transplants-work/diseases-treatable-by-transplants/. Accessed Jan. 27, 2022.
- AskMayoExpert. Cutaneous graft-versus-host disease (adult). Mayo Clinic; 2021.
- Blood and marrow stem cell transplantation. Leukemia & Lymphoma Society. https://www.lls.org/resource-center/download-or-order-free-publications. Accessed Jan. 28, 2022.
- Chao NJ. Survival, quality-of-life and late complications after hematopoietic cell transplantation in adults. https://www.uptodate.com/contents/search. Accessed Feb. 10, 2022.
- Blood and bone marrow transplant. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/blood-and-bone-marrow-transplant. Accessed Jan. 28, 2022.
- D’Souza A, et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biology of Blood and Marrow Transplantation. 2020; doi:10.1016/j.bbmt.2020.04.013.
- Hematopoietic stem cell transplantation. Merck Manual Professional Version. https://www.merckmanuals.com/professional/immunology-allergic-disorders/transplantation/hematopoietic-stem-cell-transplantation#. Accessed Feb. 10, 2022.
- Blood and marrow transplant (BMT): An introduction to allogeneic BMT. Leukemia & Lymphoma Society. https://www.lls.org/resource-center/download-or-order-free-publications. Accessed Jan. 28, 2022.
- Participating clinical centers. Primary Immune Deficiency Treatment Consortium. https://www.rarediseasesnetwork.org/cms/pidtc/Learn-More/Participating-Clinical-Centers. Accessed Feb. 18, 2022.
- Full membership institutions. Pediatric Transplantation and Cellular Therapy Consortium. http://www.pbmtc.org/about/members/full. Accessed Feb. 18, 2022.
- Participating institutions. ECOG-ACRIN Cancer Research Group. https://ecog-acrin.org/participating-institutions. Accessed Feb. 18, 2022.
- Mills SD, et al. Bone-marrow transplant in an identical twin. JAMA. 1964; doi:10.1001/jama.1964.03060380005001.
- Rashidi A, et al. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood Advances. 2019; doi:10.1182/bloodadvances.2019000050.
- Ahmed S, et al. Lower graft-versus-host disease and relapse risk in post-transplant cyclophosphamide-based haploidentical versus matched sibling donor reduced-intensity conditioning transplant for Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2019.05.025.
- Jain T, et al. Choosing a reduced-intensity conditioning regimen for allogeneic stem cell transplantation, fludarabine/busulfan versus fludarabine melphalan: A systematic review and meta-analysis. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2018.11.016.
- Chen YB, et al. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. Blood Advances. 2019; doi:10.1182/bloodadvances.2018027599.
- Ballen KK, et al. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: Comparison among alternative graft sources. Biology of Blood and Marrow Transplantation. 2014; doi:10.1016/j.bbmt.2014.07.021.
- Sweeney SK, et al. Tracking embryonic hematopoietic stem cells to the bone marrow: Nanoparticle options to evaluate transplantation efficiency. Stem Cell Research & Therapy. 2018; doi:10.1186/s13287-018-0944-8.
- Kumar A, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis: An updated systematic review and meta-analysis. Bone Marrow Transplantation. 2019; doi:10.1038/s41409-018-0393-0.
- Graff TM, et al. Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. Bone Marrow Transplant. 2015; doi:10.1038/bmt.2015.46.
- Braswell Pickering EA. Allscripts EPSi. Mayo Clinic. March 1, 2022.
- Search for a FACT accredited organization. Foundation for the Accreditation of Cellular Therapy (FACT). http://accredited.factwebsite.org/. Accessed Feb. 18, 2022.
- Transplant center search results. Be The Match. https://bethematch.org/tcdirectory/search/advanced/#mayo/-/-/false/-. Accessed Feb. 18, 2022.
- Participating transplant centers. Center for International Blood and Marrow Transplant Research. https://www.cibmtr.org/About/WhoWeAre/Centers/Pages/index.aspx?country=us&state=Minnesota. Accessed Feb. 18, 2022.
- Locations. Children’s Oncology Group. https://childrensoncologygroup.org/index.php/locations/. Accessed Feb. 18, 2022.
Ad
Women have unique health issues. And some of the health issues that affect both men and women can affect women differently.
Book your appointment TODAY!
Search on the closest Doctor to your location and book based on specialty. EARN 10 POINTS more with CuraPOINT.
BOOK